SpaceX recently completed a record IPO.

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 6.3% in the afternoon session after the European ...

Eli Lilly holds a dominant market share in the weight loss treatment category.

Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointing to 12.5% upside from a recent price of $1,199.43. We rate LLY a buy with a 90% confidence score.

At first glance, Eli Lilly's (NYSE: LLY) current share price of $903 feels like a psychological barrier. Most investors fixate on the absolute dollars and assume anything this expensive must be priced ...

Eli Lilly has made some massive breakthroughs in pharmaceutical technology, but will it translate to money for investors? Read our forecast and find out.

Eli Lilly (NYSE:LLY) just grew revenue 55.5% in a single quarter while raising full-year guidance to $82 billion to $85 billion. Mounjaro and Zepbound combined for $12.8 billion in Q1 alone. Yet ...

The consensus analyst price target suggests Eli Lilly's stock will fly past $1,000 in the near future. The stock's price-to-earnings multiple is well below what it has averaged over the past five ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, ...

There are some good reasons why investors might want to avoid Eli Lilly (NYSE: LLY). For example, its price-to-earnings ratio is high at 40x, and its yield is very low at just 0.6%. But there are also ...